Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Hydroxychloroquine

Copy Product Info
🥰Excellent
Catalog No. T9287Cas No. 118-42-3
Alias 2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol

Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.

Hydroxychloroquine

Hydroxychloroquine

Copy Product Info
🥰Excellent
Purity: 99.79%
Catalog No. T9287Alias 2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanolCas No. 118-42-3
Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 mg$30In StockIn Stock
100 mg$39In StockIn Stock
200 mg$55In StockIn Stock
500 mg$91In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.79%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Hydroxychloroquine AI Summary
Hydroxychloroquine exhibits multifaceted bioactivities and pharmacokinetic properties. It is a modulator of Lamin A splicing with a potency of 35481.3 nM and acts as a delayed-death inhibitor of malaria parasite plastid with potencies of 169.4 nM and 151.0 nM after 96-hour and 48-hour incubations, respectively. The compound shows antiviral activities against SARS-CoV-2 and Dengue virus 2, with significant potency in inhibiting viral replication in Vero E6 and BHK-21 cells. It also inhibits SARS-CoV-2 3CL-Pro protease and Zika virus NS2B-NS3 protease. Moreover, Hydroxychloroquine has antagonistic effects on TLR7 and TLR9, and demonstrates cytotoxicity against various cell lines, including African green monkey Vero cells and human A549 cells. Pharmacokinetically, Hydroxychloroquine showcases a large volume of distribution (Vdss = 700.0 L.kg-1), a long half-life (T1/2 = 850.0 hr), and a mean residence time (MRT = 1300.0 hr). It has moderate plasma protein binding (Fu = 0.57) and a clearance rate of 11.0 mL.min-1.kg-1. Upon oral administration, it reaches Tmax in 2.4 hours with a Cmax of 1220.0 nM and an AUC value of 34360.52 ng.hr.mL-1. The compound exhibits moderate to severe hepatic side effects, such as hepatic failure with a high HepSE score and moderate liver toxicity during clinical trials. In terms of receptor binding, Hydroxychloroquine shows affinity for Alpha-1D adrenergic, Imidazoline I2, Muscarinic M2 receptors, and others, with varying IC50 values. Additionally, it has shown bioactivity in inhibiting human recombinant ACE2 and cGAS in THP-1 cells, with potent inhibitory effects on certain receptors, transporters, and enzymes. Overall, Hydroxychloroquine possesses diverse bioactivities across different biological targets and demonstrates significant pharmacokinetic and toxicological profiles, indicating its potential for various therapeutic applications and the necessity for cautious consideration of its side effect profile..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Hydroxychloroquine (2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol) (HCQ) is an alkalinizing lysosomatropic drug that acts by inducing apoptosis of renal cancer cells in vitro and inhibiting TLR7/9. It is a medication used to prevent and treat malaria, and it's also being studied as an experimental treatment for COVID-19.
Synonyms2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol
Chemical Properties
Molecular Weight335.87
FormulaC18H26ClN3O
Cas No.118-42-3
SmilesCCN(CCO)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12
Relative Density.1.176 g/cm3
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 1.65 mg/mL (4.91 mM), Sonication and heating to 60℃ are recommended.
DMSO: 257 mg/mL (765.18 mM), Sonication is recommended.
1M HCl: 99 mg/mL (294.76 mM), when pH is adjusted to 2 with HCl.
Solution Preparation Table
H2O/1M HCl/DMSO
1mg5mg10mg50mg
1 mM2.9773 mL14.8867 mL29.7734 mL148.8671 mL
1M HCl/DMSO
1mg5mg10mg50mg
5 mM0.5955 mL2.9773 mL5.9547 mL29.7734 mL
10 mM0.2977 mL1.4887 mL2.9773 mL14.8867 mL
20 mM0.1489 mL0.7443 mL1.4887 mL7.4434 mL
50 mM0.0595 mL0.2977 mL0.5955 mL2.9773 mL
100 mM0.0298 mL0.1489 mL0.2977 mL1.4887 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Hydroxychloroquine | purchase Hydroxychloroquine | Hydroxychloroquine cost | order Hydroxychloroquine | Hydroxychloroquine chemical structure | Hydroxychloroquine formula | Hydroxychloroquine molecular weight